NCT00936390 Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT00931528 Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy Status COMPLETED Phase PHASE3
NCT00928603 Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment Status UNKNOWN Phase PHASE1
NCT00928174 Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00925600 Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Status COMPLETED Phase PHASE3
NCT00925418 Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer Status COMPLETED Phase PHASE3
NCT00924807 Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00924469 A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00924313 Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00924092 An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... Status COMPLETED Phase PHASE1
NCT00923104 An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin Status COMPLETED Phase N/A
NCT00922818 Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy Status WITHDRAWN Phase N/A
NCT00922129 Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer Status WITHDRAWN Phase PHASE2/PHASE3